Tenders of Dak Gesundheit

Tenders of Dak Gesundheit

DAK Gesundheit Tender

Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 Jun 2025
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Healthcare and Medicine...+1Chemical Products
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient fesoterodine, ATC G04bd11 (obg) for the period 01.08.2024 - 31.07.2026
Closing Date5 Jun 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Others
Germany
Completion of a non-exclusive discount agreement According to § 130a para. 8 Sgb W To the active ingredient Dydrogesterone + Estradiol, Atc G03fa14 For The Time 01.05.2023 - 30.04.2025 (1003891- Dydrogesterone + Estradiol, Atc G03fa14)
Closing Date5 Mar 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 Jun 2025
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 May 2025
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Others
Germany
Completion of a non-exclusive discount agreement According to § 130a para. 8 Sgb W To the active ingredient Peginterferon Beta-1a, Atc L03ab13 For The Time 01.05.2023 - 30.04.2025 (1003891- Peginterferon Beta-1a, Atc L03ab13)
Closing Date5 Mar 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 Oct 2025
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Chemical Products
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient pyridostigmine (excluding sustained-release Dafo.), (obg) ATC N07aa02 for the period 01.01.2025 - 31.12.2026
Closing Date5 Nov 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient etravirine, ATC J05ag04 (obo) for the period 01.07.2024 - 30.06.2026
Closing Date5 May 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 May 2025
Tender AmountEUR 1 (USD 1)
331-340 of 342 active Tenders